2026: A watershed year for RNA therapeutics-From breakthrough vaccines to chronic indications and beyond.

Di Nitto C, Giangrande PH

Open source

DOI
10.1016/j.omtn.2026.103085
Published
2026 Dec 8
Container
Molecular therapy. Nucleic acids
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2026.103085,
  title = {2026: A watershed year for RNA therapeutics-From breakthrough vaccines to chronic indications and beyond.},
  author = {Di Nitto C and Giangrande PH},
  year = {2026},
  journal = {Molecular therapy. Nucleic acids},
  doi = {10.1016/j.omtn.2026.103085},
  url = {https://doi.org/10.1016/j.omtn.2026.103085}
}

RIS

TY  - JOUR
TI  - 2026: A watershed year for RNA therapeutics-From breakthrough vaccines to chronic indications and beyond.
AU  - Di Nitto C
AU  - Giangrande PH
PY  - 2026
JO  - Molecular therapy. Nucleic acids
DO  - 10.1016/j.omtn.2026.103085
UR  - https://doi.org/10.1016/j.omtn.2026.103085
ER  - 

APA

C, D. N., & PH, G. (2026). 2026: A watershed year for RNA therapeutics-From breakthrough vaccines to chronic indications and beyond.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2026.103085

Source records